AI Science Tracker

National Taiwan University Hospital

1 discovery from 2022

Discoveries

Deep learning detects pancreatic cancer on CT in a nationwide study

A deep-learning tool for contrast-enhanced CT reached 89.9% sensitivity and 95.9% specificity in an internal test set (not significantly different from the original radiologist reports, 96.1%). On 1,473 real-world Taiwanese CT studies it reached 89.7% sensitivity and 92.8% specificity, but sensitivity for cancers under 2 cm was 74.7%. The study is retrospective, with no prospective reader comparison in the abstract.

Technology: Segmentation CNN with an ensemble of five CNN classifiers for pancreatic cancer on CT

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: A deep-learning CT tool was tested on an internal retrospective test set against original radiologist reports and on 1,473 real-world Taiwanese CT studies, reaching 89.7% sensitivity and 92.8% specificity in the latter.
  • Still unknown: Sensitivity for tumours under 2 cm was 74.7%; the study is retrospective with no prospective reader comparison in the abstract.
  • AI role: An end-to-end computer-aided detection tool (segmentation CNN plus an ensemble of five CNNs) detected pancreatic cancer on contrast CT.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1148/radiol.220152&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 207 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.